These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23357658)

  • 1. What does the HAMD mean?
    Leucht S; Fennema H; Engel R; Kaspers-Janssen M; Lepping P; Szegedi A
    J Affect Disord; 2013 Jun; 148(2-3):243-8. PubMed ID: 23357658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies.
    Leucht S; Fennema H; Engel RR; Kaspers-Janssen M; Lepping P; Szegedi A
    J Affect Disord; 2017 Mar; 210():287-293. PubMed ID: 28068617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking the PANSS, BPRS, and CGI: clinical implications.
    Leucht S; Kane JM; Etschel E; Kissling W; Hamann J; Engel RR
    Neuropsychopharmacology; 2006 Oct; 31(10):2318-25. PubMed ID: 16823384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity classification on the Hamilton Depression Rating Scale.
    Zimmerman M; Martinez JH; Young D; Chelminski I; Dalrymple K
    J Affect Disord; 2013 Sep; 150(2):384-8. PubMed ID: 23759278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data.
    Bobo WV; Angleró GC; Jenkins G; Hall-Flavin DK; Weinshilboum R; Biernacka JM
    Hum Psychopharmacol; 2016 May; 31(3):185-92. PubMed ID: 26999588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI.
    Levine SZ; Rabinowitz J; Engel R; Etschel E; Leucht S
    Schizophr Res; 2008 Jan; 98(1-3):318-22. PubMed ID: 17949948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the severity of psychiatric disorders using the Health of the Nation Outcome Scales: An equipercentile linking analysis.
    Egger ST; Bobes J; Theodoridou A; Seifritz E; Vetter S
    Aust N Z J Psychiatry; 2020 Dec; 54(12):1192-1199. PubMed ID: 33032447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of Brief Psychiatric Rating Scale scores.
    Leucht S; Kane JM; Kissling W; Hamann J; Etschel E; Engel R
    Br J Psychiatry; 2005 Oct; 187():366-71. PubMed ID: 16199797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
    Chaudhry HR; Qureshi Z; Tareen IA; Yazdani I
    J Pak Med Assoc; 2002 Nov; 52(11):518-25. PubMed ID: 12585372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response and remission criteria in major depression--a validation of current practice.
    Riedel M; Möller HJ; Obermeier M; Schennach-Wolff R; Bauer M; Adli M; Kronmüller K; Nickel T; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Seemüller F
    J Psychiatr Res; 2010 Nov; 44(15):1063-8. PubMed ID: 20447651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
    Lin HS; Lin CH
    J Affect Disord; 2019 Feb; 245():91-97. PubMed ID: 30368075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials.
    Samara MT; Levine SZ; Leucht S
    Pharmacopsychiatry; 2023 Jan; 56(1):18-24. PubMed ID: 35896419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD).
    Ballesteros J; Bobes J; Bulbena A; Luque A; Dal-Ré R; Ibarra N; Güemes I
    J Affect Disord; 2007 Sep; 102(1-3):93-9. PubMed ID: 17258323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
    Cao Y; Li W; Shen J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking.
    Furukawa TA; Reijnders M; Kishimoto S; Sakata M; DeRubeis RJ; Dimidjian S; Dozois DJA; Hegerl U; Hollon SD; Jarrett RB; Lespérance F; Segal ZV; Mohr DC; Simons AD; Quilty LC; Reynolds CF; Gentili C; Leucht S; Engel RR; Cuijpers P
    Epidemiol Psychiatr Sci; 2019 Mar; 29():e24. PubMed ID: 30867082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression.
    Turkoz I; Fu DJ; Bossie CA; Sheehan JJ; Alphs L
    J Affect Disord; 2013 Aug; 150(1):17-22. PubMed ID: 23517884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales.
    Zhang CY; Voort JLV; Yuruk D; Mills JA; Emslie GJ; Kennard BD; Mayes T; Trivedi M; Bobo WV; Strawn JR; Athreya AP; Croarkin PE
    J Child Adolesc Psychopharmacol; 2022 Jun; 32(5):278-287. PubMed ID: 35704877
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing the severity of functional impairment of psychiatric disorders: equipercentile linking the mini-ICF-APP and CGI.
    Egger ST; Weniger G; Müller M; Bobes J; Seifritz E; Vetter S
    Health Qual Life Outcomes; 2019 Nov; 17(1):174. PubMed ID: 31744498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.